Japan Intellectual Property Rights: AMORPHOUS AND CRYSTALLINE FORM OF GENZ 112638 HEMITARTRATE AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE

Japan, Sept. 28 -- GENZYME CORP has got intellectual property rights for 'AMORPHOUS AND CRYSTALLINE FORM OF GENZ 112638 HEMITARTRATE AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE.' Other related details are as follows:

Application Number: JP,2023-101301

Category (FI): A61K47/32,A61P43/00,121,A61K38/47,A61P7/06,A61P3/06,A61P3/00,A61K9/48,A61K47/14,A61K38/16,A61K47/12,A61K47/44,A61K47/46,A61K47/42,A61K47/36,A61K47/38,A61K47/26,A61K31/445,A61K38/43,A61K45/00,A61K31/4025,C07D319/18,A61P43/00,111,A61P17/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 21, 2023

Publication Date: Aug. 22, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.